References
- Bowen R. C, Cipywnyk D., D'Arcy C. Alcoholism, anxiety disorders, and agoraphobia. Alcoholism: Clin. Exp. Res. 1984; 8(l)48–50
- Powell B. J., Penick E. C, Othmer E. Prevalence of additional psychiatric syndromes among male alcoholics. J. Clin. Psychiatry 1982; 43(10)404–407
- Liebowitz M. R., Fyer A. J., Gorman J. M. Lactate provocation of panic attacks. Arch. Gen. Psychiatry 1984; 41: 764–770
- Chouninard G., Labonte A., Fontaine R. New concepts in benzodiazepine therapy: Rebound anxiety and new indications for the more potent benzodiazepines. Prog. Neuro- psychopharmacol. Biol. Psychiatry 1983; 7: 669–673
- Pollack M. H., Tesar G. E., Rosenbaum J. F. Clonazepam in the treatment of panic disorder and agoraphobia: A one year follow-up. J. Clin. Psychopharmacol. 1986; 6(5)302–304
- Beaudry P., Fontaine R., Chouinard G. Clonazepam in the treatment of patients with recurrent panic attacks. J. Clin. Psychiatry 1986; 47: 83–85
- American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders 3rd ed. American Psychiatric Association, Washington, D.C. 1987; 230–232
- Zitrin C, Klein D., Woerner M. Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. Arch. Gen. Psychiatry 1983; 40: 125–138
- Cohen M., Badel D., Kilpatrick A. The high familial prevalence of neurocirculatory asthenia (anxiety neurosis, effort syndrome). Am. J. Hum. Genet. 1951; 3: 126–158
- Terhune W. B. The phobic syndrome: A study of eighty-six patients with phobic reactions. Arch. Neurol. Psychiatry (Chicago) 1949; 62: 162–172
- Sim M., Houghton H. Phobic anxiety and its treatment. J. Nerv. Ment. Dis. 1966; 143: 484–491
- Quitkin F. M., Rifkin A., Kaplas J. Phobic anxiety syndrome complicated by drug dependence and addiction: A treatable form of drug abuse. Arch. Gen. Psychiatry 1972; 27: 159–162
- Hudson C. J., Perkins S. H. Panic disorder and alcohol misuse. J. Stud. Alcohol 1984; 45(5)462–464
- Marks I., Gray S., Cohen D. Imipramane and brief therapist-aided exposure in agoraphobics having self-exposure homework. Arch. Gen. Psychiatry 1983; 40: 153–162
- Sheehan D. V. Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: Implications for classification. J. Clin. Psychiatry 1984; 45(7, pt 2)29–36
- Sheehan D. V., Coleman J. H., Greenblatt D. J. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. J. Clin. Psychopharmacol. 1984; 4(2)66–75
- Sellers E. M., Busto U. Benzodiazepines and ethanol: Assessment of the effects and consequences of psychotropic drug interactions. J. Clin. Psychopharmacol. 1982; 2(4)249–262
- Smail P., Stockwell T., Canter S. Alcohol dependence and phobic states. I. A prevalence study. Br. J. Psychiatry 1979; 135: 565–573
- Shader R. I., Goodman M., Gever J. Panic disorders: Current perspectives. J. Clin. Psychopharmacol. 1982; 2: 25–105
- Noyes R., Jr., Anderson D. J., Clancy J. Diazepam and propranolol in panic disorder and agoraphobia. Arch. Gen. Psychiatry 1984; 41: 287
- Jaffe J. H., Ciraulo D. A. Drugs used in the treatment of alcoholism. The Diagnosis 2nd ed., J. H. Mendelson, N. K. Mello. McGraw-Hill, New York 1985; 355–389, and Treatment of Alcoholism